We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Barr Pharmaceuticals today announced that the Croatian Financial Services Supervisory Agency (HANFA) has approved for publication its amended tender offer for the purchase of 100 percent of the shares of Pliva, based in Zagreb, Croatia.
Japanese drugmaker Eisai has signed a $205 million product acquisition agreement with Ligand Pharmaceuticals in which Eisai obtained exclusive global rights for ONTAK (denileukin diftitox), Targretin (bexarotene) capsules, Targretin (bexarotene) gel 1 percent and Panretin (alitretinoin) gel 0.1 percent.
Graffinity Pharmaceuticals GmbH announced that it has entered into a research collaboration with Boehringer Ingelheim Pharmaceuticals, Inc. which involves four global research sites of Boehringer Ingelheim.
Dynavax Technologies Corporation has entered into a research collaboration and license agreement with AstraZeneca for the discovery and development of TLR-9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Dutch biotechnology company Crucell N.V. announced that it has signed a STAR licensing agreement with UCB, a leading biopharmaceutical company with headquarters in Brussels, making UCB the first European STAR licensee.
GlaxoSmithKline urged the world's richest countries yesterday to help fill an estimated $35bn funding gap needed by 2015 to bring new vaccines to their biggest patient population -- developing countries.
Sanofi-aventis and Bristol-Myers Squibb Company announced that the European Commission has granted a new indication for the antiplatelet agent PLAVIX (clopidogrel bisulfate) to include patients with ST-segment Elevation acute Myocardial Infarction (STEMI) who are eligible for thrombolytic therapy.
Shareholders of Dutch chemical, coatings and drug company Akzo Nobel NV on Thursday approved the company's plan to spin-off its pharmaceuticals unit, Organon BioSciences.